British grocery chain Sainsbury’s
is selling its in-store pharmacy
business to German giant Celesio,
which owns the Lloyds Pharmacy
group and was itself purchased by
US health company McKesson two
years ago (PD 25 Oct 13).
Under the £125m deal Celesio
will operate all of the pharmacies
within J. Sainsbury stores across
the UK, and will pay rent for the
locations where it operates.
Sainsbury ceo Mike Coupe said
“working with a specialist operator
like Lloyds Pharmacy will enable us
to grow and extend our pharmacy
services to customers, whilst
realising value for shareholders”.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jul 15
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.